Attached files

file filename
EX-2.1 - EXHIBIT 2.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex21.htm
EX-10.4 - EXHIBIT 10.4 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex104.htm
EX-21.1 - EXHIBIT 21.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex211.htm
EX-23.1 - EXHIBIT 23.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex231.htm
EX-31.1 - EXHIBIT 31.1 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex311.htm
EX-31.2 - EXHIBIT 31.2 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex312.htm
EX-10.8 - EXHIBIT 10.8 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex108.htm
EX-10.18 - EXHIBIT 10.18 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1018.htm
EX-10.17 - EXHIBIT 10.17 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1017.htm
EX-10.16 - EXHIBIT 10.16 - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl12262015-ex1016.htm
10-K - 10-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.crl1226201510k.htm



Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K for the year ended December 26, 2015 of Charles River Laboratories International, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, James C. Foster, Chairman, Chief Executive Officer and President of the Company, and David R. Smith, Chief Financial Officer of the Company, each hereby certifies, to the best of his knowledge and pursuant to 18 U.S.C. Section 1350, that:
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:
February 12, 2016
 
/s/ JAMES C. FOSTER
 
 
 
Chairman, President and Chief Executive Officer
Charles River Laboratories International, Inc.
 
 
 
 
Dated:
February 12, 2016
 
/s/ DAVID R. SMITH
 
 
 
Corporate Executive Vice President and Chief
Financial Officer
Charles River Laboratories International, Inc.

This certification shall not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.